[Hemophagocytic syndrome complicating adult's seropositive rheumatoid arthritis]. 2004

A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
Clinique médicale 1, CHU A.-Le-Dantec, Dakar, Sénégal. niangabdou@yahoo.com <niangabdou@yahoo.com>

BACKGROUND Macrophage activation syndrome (MAS) is a severe complication of chronic rheumatic diseases, particularly juvenile rheumatoid arthritis. However, MAS is rarely described in adult rheumatoid polyarthritis. METHODS We report a case of MAS complicating a seropositive rheumatoid polyarthritis after 20 years of evolution. Pancytopenia with fever, renal failure and hepatic dysfunction revealed the disease that was confirmed by multiple macrophages and monocytes invading the bone marrow specimen. CONCLUSIONS Outcome has been spectacular under corticosteroids.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D015616 Histiocytosis, Non-Langerhans-Cell Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases (SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES). Reticulohistiocytoma,Xanthoma Disseminatum,Disseminatum, Xanthoma,Histiocytosis, Non Langerhans Cell,Non-Langerhans-Cell Histiocytosis,Reticulohistiocytomas
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
January 2007, Internal medicine (Tokyo, Japan),
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
January 1998, Journal of pediatric hematology/oncology,
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
December 2013, Joint bone spine,
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
October 1998, Ryumachi. [Rheumatism],
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
October 2011, Modern rheumatology,
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
October 1994, Internal medicine (Tokyo, Japan),
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
June 1969, Annals of internal medicine,
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
May 1966, Southern medical journal,
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
May 1958, British medical journal,
A Niang, and S Diallo, and M M Ka, and A Pouye, and S Diop, and S Ndongo, and T M Diop
September 2006, Rheumatology (Oxford, England),
Copied contents to your clipboard!